Trials

MEK 162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E Mutations

Cancer type: Solide tumores

Phase: I

Principal Investigator: Guren Tormod

Country: NO

Keywords: Norway, Oslo University Hospital

Status: Inclusion completed

Link to Clinicaltrials.gov: http://www.clinicaltrials.gov/ct2/show/NCT01352273?term=CMEK162X2102&rank=1